Metraipolis › archive › dc_2af90decce6c

Elucidating Tumorigenesis Mechanisms and Assessing Immunotherapeutic Efficacy in Patient-Derived Medulloblastoma Organoid Models — Europe PMC PMID:42157926

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42157926
DOI
10.7150/ijbs.116040
License (as archived)
solo-consultazione
Archived
2026-11-03T06:39:35.115Z
SHA-256 of the archived text
778f4ac1c10205b4c1e3e0464b072e6a0d17254a044ccbdd374e8d1b23e125b8
Stable URL of this page
https://metraipolis.com/documento/dc_2af90decce6c

How to cite

Elucidating Tumorigenesis Mechanisms and Assessing Immunotherapeutic Efficacy in Patient-Derived Medulloblastoma Organoid Models — Europe PMC PMID:42157926 — Europe PMC (en), https://europepmc.org/article/MED/42157926 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2af90decce6c (Metraipolis archive dc_2af90decce6c, sha256 778f4ac1c10205b4c1e3e0464b072e6a0d17254a044ccbdd374e8d1b23e125b8)
BibTeX
@misc{dc2af90decce6c,
  title = {Elucidating Tumorigenesis Mechanisms and Assessing Immunotherapeutic Efficacy in Patient-Derived Medulloblastoma Organoid Models — Europe PMC PMID:42157926},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42157926},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2af90decce6c; sha256 778f4ac1c10205b4c1e3e0464b072e6a0d17254a044ccbdd374e8d1b23e125b8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42157926. Agents can read the archived copy with the MCP tool read_document.